Proposed Data Collection Submitted for Public Comment and Recommendations, 47955-47957 [2024-12232]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 108 / Tuesday, June 4, 2024 / Notices
the online instructions for submitting
comments. Do not submit electronically
any information you consider to be
Confidential Business Information (CBI)
or other information whose disclosure is
restricted by statute. Additional
instructions on commenting and visiting
the docket, along with more information
about dockets generally, is available at
https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
Charles Smith, Director, Registration
Division (7505M), Office of Pesticide
Programs, Environmental Protection
Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460–0001; telephone
number: (202) 566–1030; email address:
RDFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. The following
list of North American Industrial
Classification System (NAICS) codes is
not intended to be exhaustive, but rather
provides a guide to help readers
determine whether this document
applies to them. Potentially affected
entities may include:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
ddrumheller on DSK120RN23PROD with NOTICES1
B. What should I consider as I prepare
my comments for EPA?
1. Submitting CBI. Do not submit CBI
to EPA through email or https://
www.regulations.gov. If you wish to
include CBI in your comment, please
follow the applicable instructions at
https://www.epa.gov/dockets/
commenting-epa-dockets#rules and
clearly mark the information that you
claim to be CBI. Information so marked
will not be disclosed except in
accordance with procedures set forth in
40 CFR part 2.
2. Tips for preparing your comments.
When preparing and submitting your
comments, see guidance provided at
https://www.epa.gov/dockets/
commenting-epa-dockets.
II. Registration Application
EPA has received the following
application to register new uses for a
new pesticide product containing a
currently registered active ingredient.
Pursuant to FIFRA section 3(c)(4) (7
U.S.C. 136a(c)(4)), EPA is hereby
VerDate Sep<11>2014
17:15 Jun 03, 2024
Jkt 262001
providing notice of receipt of this
application and an opportunity to
comment on the information provided
below as well as the current proposed
labeling associated with this
application. Notice of receipt of this
application does not imply a decision
by the Agency on this application.
File Symbol: 7969–LNT. Docket ID
number: EPA–HQ–OPP–2024–0154.
Applicant: BASF Corporation, 26 Davis
Drive, Research Triangle Park, North
Carolina 27709–3528. Active ingredient:
Dicamba. Product type: Herbicide.
Proposed use: Dicamba-tolerant cotton
and dicamba-tolerant soybeans. Contact:
RD. This proposed new use has been
coded as an R170, additional food use,
which carries a PRIA 5 statutory review
time of 17 months from the date that the
action gets in-processed. Because EPA
expects a large stakeholder interest in
this application, EPA also included in
the docket the BASF’s current proposed
labeling associated with the application.
47955
operating-permits/title-v-petitiondatabase.
The EPA
received a petition from the Center for
Biological Diversity dated September
19, 2023, requesting that the EPA object
to the issuance of operating permit no.
02OPWE252 issued by CDPHE to DCP
Operating Company, LP in Weld
County, Colorado. On April 2, 2024, the
EPA Administrator issued an order
granting in part and denying in part the
petition. The order itself explains the
basis for the EPA’s decision.
Sections 307(b) and 505(b)(2) of the
CAA provide that a petitioner may
request judicial review of those portions
of an order that deny issues in a
petition. Any petition for review shall
be filed in the United States Court of
Appeals for the appropriate circuit no
later than August 5, 2024.
SUPPLEMENTARY INFORMATION:
KC Becker,
Regional Administrator, Region 8.
(Authority: 7 U.S.C. 136 et seq.)
[FR Doc. 2024–12217 Filed 6–3–24; 8:45 am]
Dated: May 29, 2024.
Charles Smith,
Director, Registration Division, Office of
Pesticide Programs.
BILLING CODE 6560–50–P
[FR Doc. 2024–12109 Filed 6–3–24; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 6560–50–P
Centers for Disease Control and
Prevention
ENVIRONMENTAL PROTECTION
AGENCY
[FRL–11970–01–R8]
Clean Air Act Operating Permit
Program; Order on Petition for
Objection to State Operating Permit for
DCP Operating Company, LP:
Platteville Natural Gas Processing
Plant
Environmental Protection
Agency (EPA).
ACTION: Notice of final order on petition.
AGENCY:
The Environmental Protection
Agency (EPA) Administrator signed an
order dated April 2, 2024, granting a
petition dated September 19, 2023, from
the Center for Biological Diversity. The
petition requested that the EPA object to
the Clean Air Act (CAA) operating
permits issued by the Colorado
Department of Public Health and
Environment (CDPHE) to DCP Operating
Company, LP for its Platteville Natural
Gas Processing Plant, located in Weld
County, Colorado.
FOR FURTHER INFORMATION CONTACT:
Donald Law, EPA Region 8, telephone
number: (303) 312–7015, email address:
law.donald@epa.gov. The final order
and petition are available electronically
at: https://www.epa.gov/title-vSUMMARY:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
[60Day–24–24FY; Docket No. CDC–2024–
0046]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Lung Function
Screening of Construction Workers with
Exposure to Dusts and Chemicals. The
goal of the proposed study is to
determine if small airway dysfunction
or early-stage disease can consistently
be identified in high-risk workers with
normal spirometry.
DATES: CDC must receive written
comments on or before August 5, 2024.
SUMMARY:
E:\FR\FM\04JNN1.SGM
04JNN1
47956
Federal Register / Vol. 89, No. 108 / Tuesday, June 4, 2024 / Notices
You may submit comments,
identified by Docket No. CDC–2024–
0046 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
ADDRESSES:
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Lung Function Screening in
Construction Workers Exposed to Dusts
and Chemicals—New—National
Institute for Occupational Safety and
Health (NIOSH), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Construction workers are routinely
exposed to a number of inhaled toxins
known to contribute to the development
of chronic respiratory disease. A 2010
industry study suggested that over 50%
of construction workers reported
occupational exposure to vapors, gases,
dusts, and fumes (VGDF) at least twice
a week and that nearly 18% of everemployed construction industry
workers have abnormal lung function.
In fact, construction workers are
approximately 1.64 times more likely to
have airway obstruction than other
working groups within the U.S. trades.
An emerging lung function test
procedure called impulse oscillometry
(IOS) is more sensitive than spirometry,
the standard test for monitoring worker
pulmonary function. IOS can identify
small airway functional status with the
potential to identify those with often
reversible abnormalities within the
small airways (<2mm diameter). Thus,
the goal of the proposed study is to
determine if small airway dysfunction
or early-stage disease can consistently
be identified by IOS in high-risk
workers with normal spirometry.
Two construction worker groups will
be enrolled: (1) those at risk for
respirable silica exposure (i.e.,
blockmasons or bricklayers); and (2)
workers with occupational exposure to
welding fumes and metals (i.e.,
welders). NIOSH researchers will collect
questionnaire information pertaining to
respiratory symptomology, smoking
history, job-type tenure, worksite
mitigation strategies, and personal
protective equipment use. Height,
weight, blood pressure and lung
function testing measures will also be
performed. The amount of personal
identifiable information collected will
be limited, but it is necessary to collect
each worker’s age, month and year of
birth, sex assigned at birth, race/
ethnicity, and smoking history to
evaluate lung function test results.
Additional medical data will be
collected to reduce the risk of adverse
effects or transmission of infectious
disease to subjects performing lung
function.
CDC requests a two-year OMB
approval for an estimate 83 annual
burden hours. There is no cost to
respondents other than their time to
participate.
ddrumheller on DSK120RN23PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Informed Consent ..............................
Height, Weight, and Demographics ..
Study Questionnaire ..........................
Spirometry Test Report .....................
75
75
75
75
1
1
1
1
20/60
10/60
10/60
15/60
25
13
13
19
Oscillometry Test Report ...................
75
1
10/60
13
............................................................
....................
........................
..........................
83
Form name
Eligible Study Participants .................
Study Participants ..............................
Study Participants ..............................
Spirometry Lung Function Test Results.
Impulse Oscillometry Test Results ....
Total ............................................
VerDate Sep<11>2014
17:15 Jun 03, 2024
Average
burden per
response
(in hours)
Number of
respondents
Type of respondents
Jkt 262001
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
E:\FR\FM\04JNN1.SGM
04JNN1
Total
burden
(in hours)
Federal Register / Vol. 89, No. 108 / Tuesday, June 4, 2024 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–12232 Filed 6–3–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–24–0900; Docket No. CDC–2024–
0045]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Contact Investigation Outcome
Reporting Forms. The project includes
the contact investigation outcome
reporting forms used to obtain data from
State, local, and territorial public health
professionals or conveyance operators
and medical professionals on their
contact tracing efforts to better assess
the risk to individuals who may have
been exposed to a confirmed case of a
communicable disease of public health
concern while traveling to or within the
United States.
DATES: CDC must receive written
comments on or before August 5, 2024.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0045 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:15 Jun 03, 2024
Jkt 262001
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Contact Investigation Outcome
Reporting Forms (OMB Control No.
0920–0900, Exp. 8/31/2024)—
Revision—National Center for Emerging
and Zoonotic Infectious Diseases
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
47957
(NCEZID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
This proposed information collection
project includes the contact
investigation outcome reporting
information collection tools used by
CDC to better assess the risk to interstate
and arriving international travelers who
may have been exposed to a confirmed
case of a communicable disease of
public health concern while traveling.
Different forms are tailored for different
diseases of public health concern that
are tracked by the Division of Global
Migration Health (DGMH/CDC). The
information will be used to assist and
collaborate with State, local, and
territorial health departments,
conveyance operators, air, maritime,
and land port of entry partners, and
international public health authorities
to identify potential exposures and to
determine the risk of infection, and
whether future public health
interventions are needed.
Methods used to collect the
information are basic surveys of
respondents that record information
about the exposed traveler’s location
and activities on air or maritime
conveyances or land border crossing,
other potential exposures, signs/
symptoms that may have occurred after
their potential exposure, prior history of
vaccination or disease, and other
medical conditions that could influence
the risk of infection or severity of
illness.
Due to the COVID–19 pandemic, CDC
modified how cruise ships report
information on cases of influenza-likeillness. Since December 2023, CDC has
been using a new surveillance system
for cumulative acute respiratory illness
(ARI) reporting (under OMB Control
Number 0920–1335), which includes
cases of influenza, COVID–19, and
respiratory syncytial virus. One form
(the Influenza Outbreak Enhanced Data
Collection Form) is not used routinely
now; however, this form may be used in
limited circumstances in the future. The
burden of outcome reporting forms has
been adjusted based on more recent
numbers, which notably excludes
COVID–19 numbers because we are no
longer requiring contact investigations
for COVID–19 and thus these are lower
than past estimates. This applies
primarily to the General Contact
Investigation Outcome Reporting Form.
Other burden estimates have been
adjusted to reflect current estimates
reflecting 2021–2023 numbers.
CDC requests OMB approval for an
estimated 50 annual burden hours.
E:\FR\FM\04JNN1.SGM
04JNN1
]]>Agencies
[Federal Register Volume 89, Number 108 (Tuesday, June 4, 2024)]
[Notices]
[Pages 47955-47957]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12232]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-24-24FY; Docket No. CDC-2024-0046]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled Lung Function Screening of Construction Workers with Exposure to
Dusts and Chemicals. The goal of the proposed study is to determine if
small airway dysfunction or early-stage disease can consistently be
identified in high-risk workers with normal spirometry.
DATES: CDC must receive written comments on or before August 5, 2024.
[[Page 47956]]
ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0046 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Lung Function Screening in Construction Workers Exposed to Dusts
and Chemicals--New--National Institute for Occupational Safety and
Health (NIOSH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Construction workers are routinely exposed to a number of inhaled
toxins known to contribute to the development of chronic respiratory
disease. A 2010 industry study suggested that over 50% of construction
workers reported occupational exposure to vapors, gases, dusts, and
fumes (VGDF) at least twice a week and that nearly 18% of ever-employed
construction industry workers have abnormal lung function. In fact,
construction workers are approximately 1.64 times more likely to have
airway obstruction than other working groups within the U.S. trades.
An emerging lung function test procedure called impulse
oscillometry (IOS) is more sensitive than spirometry, the standard test
for monitoring worker pulmonary function. IOS can identify small airway
functional status with the potential to identify those with often
reversible abnormalities within the small airways (<2mm diameter).
Thus, the goal of the proposed study is to determine if small airway
dysfunction or early-stage disease can consistently be identified by
IOS in high-risk workers with normal spirometry.
Two construction worker groups will be enrolled: (1) those at risk
for respirable silica exposure (i.e., blockmasons or bricklayers); and
(2) workers with occupational exposure to welding fumes and metals
(i.e., welders). NIOSH researchers will collect questionnaire
information pertaining to respiratory symptomology, smoking history,
job-type tenure, worksite mitigation strategies, and personal
protective equipment use. Height, weight, blood pressure and lung
function testing measures will also be performed. The amount of
personal identifiable information collected will be limited, but it is
necessary to collect each worker's age, month and year of birth, sex
assigned at birth, race/ethnicity, and smoking history to evaluate lung
function test results. Additional medical data will be collected to
reduce the risk of adverse effects or transmission of infectious
disease to subjects performing lung function.
CDC requests a two-year OMB approval for an estimate 83 annual
burden hours. There is no cost to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Eligible Study Participants.... Informed Consent. 75 1 20/60 25
Study Participants............. Height, Weight, 75 1 10/60 13
and Demographics.
Study Participants............. Study 75 1 10/60 13
Questionnaire.
Spirometry Lung Function Test Spirometry Test 75 1 15/60 19
Results. Report.
Impulse Oscillometry Test Oscillometry Test 75 1 10/60 13
Results. Report.
-------------------------------------------------------------
Total...................... ................. ........... .............. ............... 83
----------------------------------------------------------------------------------------------------------------
[[Page 47957]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-12232 Filed 6-3-24; 8:45 am]
BILLING CODE 4163-18-P
